We found marked chromosomal abnormalities in a patient with lymphoma who was treated with intraarticular radioactive gold ("'5Au) for severe RA.3 Although we were tempted to conclude the chromosomal abnormalities found in our patient were due to her "98Au treatment, we were unable to exclude the possibility that the phenylbutazone and prednisone treatments or the deveolpment of her lymphoma or RA may have been the cause of the chromosomal abnormalities. This communication reports our chromosomal findings of 21 RA patients with various treatments and of 28 controls.
Heparinised peripheral blood was obtained for cytogenetic studies from 21 active RA patients. Five patients received 10 mCi of intra-articular "9Au; 14 received intramuscular nonradioactive gold; and 2 received full therapeutic doses of aspirin (7800 mg/day). The controls consisted of 28 hospital employees without any known illnesses. Peripheral blood was cultured in TC 199 tissue culture medium, enriched with either autologous plasma or fetal calf serum and stimulated with phytohemagglutinin (PHA) according to the method used in our laboratory.3 After incubation at 37°C for three days the cultures were exposed to colcemid at a concentration of 0-16 Aglml for one hour. The cells were then exposed to 0 075 M KC1 for half an hour, fixed with acetoalcohol, and the slides made by the air-dried method. The slides were stained with Giemsa and analysed for chromosomal breakages as described. 4 The mean rate of chromosomal breakages was 8-6 ± 2-4 (SEM) in the 5 RA patients treated with 9'Au; 9 4 + in our patients with lymphoma, treated with "9'Au for her RA, must not have been caused by the radioactivity of the '98Au per se. This conclusion is based on our present finding that significant chromosomal breakages are also seen in RA patients treated with nonradioactive gold. Although it is possible that the chromosomal abnormalities found in our RA patients were associated with their primary disease rather than their treatment, we cannot make this conclusion based on our present data, since all our patients were treated with various methods. Also, it is not possible to study RA patients not treated with aspirin to rule out this possibility.
